share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

艾伯維公司 | 4:持股變動聲明-董事 Alpern Robert J
美股SEC公告 ·  10/03 05:05

牛牛AI助理已提取核心訊息

In a recent transaction dated 09/30/2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], has been involved in a financial action. The specifics of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. Consequently, the number of shares held by Alpern after the action remains unknown. This information is critical for investors monitoring insider activities and market movements related to AbbVie's stock.
In a recent transaction dated 09/30/2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], has been involved in a financial action. The specifics of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. Consequently, the number of shares held by Alpern after the action remains unknown. This information is critical for investors monitoring insider activities and market movements related to AbbVie's stock.
在最近的一筆交易中,與艾伯維公司(ABBV)有關的Robert J Alpern參與了一項財務行動。具體交易細節,包括涉及的股票數量、股票性質、交易價格以及股票的總價值均未披露。因此,Alpern在此次行動後持有的股票數量仍然未知。這些信息對於監控內部交易活動以及與艾伯維公司股票相關的市場走勢的投資者至關重要。
在最近的一筆交易中,與艾伯維公司(ABBV)有關的Robert J Alpern參與了一項財務行動。具體交易細節,包括涉及的股票數量、股票性質、交易價格以及股票的總價值均未披露。因此,Alpern在此次行動後持有的股票數量仍然未知。這些信息對於監控內部交易活動以及與艾伯維公司股票相關的市場走勢的投資者至關重要。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。